Meet the METs

Researchers at Queen Mary, University of London have found that blocking endocytosis could treat MET-mutant cancers resistant to current treatments.¹ Developing a safe way to inhibit the essential cellular process could prove challenging.

Endocytosis is a process by which the cell takes up extracellularmolecules including proteins for recycling or degradation. The process influences cell migration, survival and receptor signaling.^2,3...